Kristian J. Tangso, Quy Phuong Ho and Ben J. Boyd Pages 56 - 62 ( 7 )
Conventional dosage forms such as tablets, capsules and syrups are prescribed in the normal course of practice. However, concerns about patient preferences and market demands have given rise to the exploration of novel unconventional dosage forms. Among these, confectionery-based dose forms have strong potential to overcome compliance problems. This report will review the availability of these unconventional dose forms used in treating the oral cavity and for systemic drug delivery, with a focus on medicated chewing gums, medicated lollipops, and oral bioadhesive devices. The aim is to stimulate increased interest in the opportunities for innovative new products that are available to formulators in this field, particularly for atypical patient populations.
Bioadhesives, chewing gum, drug delivery, lollipops, medicated confectionaries, oral administration.
Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus) 381 Royal Parade, Parkville, Victoria.